Literature DB >> 10667526

Post-intensive care unit pediatric hospital stay and estimated costs.

R K Kanter1.   

Abstract

OBJECTIVE: For pediatric intensive care unit (ICU) survivors, to determine the proportion of hospital stay and estimated hospital costs accounted for by post-ICU care.
DESIGN: Prospective study.
SETTING: University teaching hospital. PATIENTS: Pediatric patients who survive an ICU admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Estimated relative daily costs were assumed as follows: ICU, with ventilator/ICU, not on ventilator/intermediate care unit/general pediatric hospital day, at 2:1:0.7:0.3, respectively. Estimated costs were expressed in arbitrary units as (number of days at each level of care) x (relative cost per day). The ICU phase was defined as the patient's first ICU admission only, and the post-ICU phase included intermediate care unit and general pediatric hospital days, as well as ICU readmission during the same hospitalization. Pre-ICU hospital activity was excluded from analysis. For 341 ICU survivors, post-ICU days (median, 4 days per patient) accounted for 62% of the total hospital stay. Post-ICU care accounted for one third of the total estimated hospital costs for ICU survivors. Patients with longer post-ICU stays could not be reliably identified at the time of ICU discharge according to their ICU length of stay, duration of mechanical ventilation in the ICU, age, ICU day 1 mortality probability, or diagnostic group (p>.05).
CONCLUSIONS: Post-ICU care accounts for a substantial proportion of hospital stay and estimated costs for ICU survivors. These observations suggest that developing strategies to optimize hospital utilization at the time of ICU discharge may be important for controlling costs of recovery from critical illness.

Entities:  

Mesh:

Year:  2000        PMID: 10667526     DOI: 10.1097/00003246-200001000-00036

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

Review 1.  Intensive care--a cost effective option for developing countries?

Authors:  R C Sachdeva
Journal:  Indian J Pediatr       Date:  2001-04       Impact factor: 1.967

2.  Repeated Critical Illness and Unplanned Readmissions Within 1 Year to PICUs.

Authors:  Jeffrey D Edwards; Adam R Lucas; W John Boscardin; R Adams Dudley
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

3.  A day in the life.

Authors:  Derek S Wheeler; Erika L Stalets
Journal:  Transl Pediatr       Date:  2018-10

4.  Direct Cost of Critical Illness Associated Healthcare Expenditures among Children Admitted in Pediatric Intensive Care Unit in Rural India.

Authors:  Vivek V Shukla; Somashekhar M Nimbalkar; Jaishree D Ganjiwale; Denny John
Journal:  Indian J Pediatr       Date:  2016-06-01       Impact factor: 1.967

5.  Daily estimation of the severity of multiple organ dysfunction syndrome in critically ill children.

Authors:  Stéphane Leteurtre; Alain Duhamel; Bruno Grandbastien; François Proulx; Jacques Cotting; Ronald Gottesman; Ari Joffe; Bendicht Wagner; Philippe Hubert; Alain Martinot; Jacques Lacroix; Francis Leclerc
Journal:  CMAJ       Date:  2010-06-14       Impact factor: 8.262

6.  Frequency, risk factors, and outcomes of early unplanned readmissions to PICUs.

Authors:  Jeffrey D Edwards; Adam R Lucas; Patricia W Stone; W John Boscardin; R Adams Dudley
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

7.  Differences in organ dysfunctions between neonates and older children: a prospective, observational, multicenter study.

Authors:  Nawar Bestati; Stéphane Leteurtre; Alain Duhamel; François Proulx; Bruno Grandbastien; Jacques Lacroix; Francis Leclerc
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

8.  A comparative two-cohort study of pediatric patients with long term stay in ICUs.

Authors:  Julia García Mancebo; Sara de la Mata Navazo; Estíbaliz López-Herce Arteta; Rosario Montero Mateo; Isabel María López Esteban; Adriana Mazzuchelli Domínguez; María Sánchez Doutel; Jesús López-Herce Cid; Rafael González Cortés
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.